BeOne Medicines (ONC) Return on Invested Capital Growth (5y) (2021 - 2026)

BeOne Medicines (ONC) Return on Invested Capital Growth (5y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00
Dec 31, 2025 8.00
Sep 30, 2025 34.00
Jun 30, 2025 49.00
Mar 31, 2025 60.00
Dec 31, 2024 42.00
Sep 30, 2024 27.00
Jun 30, 2024 19.00
Mar 31, 2024 21.00
Dec 31, 2023 18.00
Sep 30, 2023 13.00
Jun 30, 2023 7.00
Mar 31, 2023 5.00
Dec 31, 2022 5.00
Sep 30, 2022 4.00
Jun 30, 2022 73.00
Sep 30, 2021 5.00
Jun 30, 2021 2.00
Mar 31, 2021 -1.00